We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Clinical Trial FAQ Library

Find answers to commonly asked questions regarding clinical trials, expanded access programs, or compassionate use.


If you are unable to find the answers you need, please contact our Clinical Trial Information Support team at (888) 662-6728, Monday-Friday, 5am-5pm PT.